Institutional investors purchased a net $28.3 thousand shares of MDGL during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 8.90% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 114.9 Thousand shares of Madrigal Pharmaceuticals ...
ROCK SPRINGS CAPITAL MANAGEMENT ... Bought 63.0 Thousand shares of Madrigal Pharmaceuticals ...